|
|
Volumn 329, Issue 5990, 2010, Pages 374-375
|
|
At last, vaginal gel scores victory against HIV
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MICROBICIDE;
TENOFOVIR;
ADENINE;
AGENTS USED INTRAVAGINALLY;
DRUG DERIVATIVE;
PHOSPHONIC ACID DERIVATIVE;
TOPICAL ANTIINFECTIVE AGENT;
ABSENCE OF SIDE EFFECTS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
CONDOM;
CONTRACEPTION;
GEL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
INFECTION RISK;
NOTE;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PRIORITY JOURNAL;
RISK REDUCTION;
SEXUAL BEHAVIOR;
SEXUAL TRANSMISSION;
SOUTH AFRICA;
VAGINA RING;
VIRUS TRANSMISSION;
ADOLESCENT;
ADULT;
DISEASE TRANSMISSION;
DRUG EFFECT;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS 1;
RANDOMIZED CONTROLLED TRIAL;
ADENINE;
ADOLESCENT;
ADULT;
ANTI-HIV AGENTS;
ANTI-INFECTIVE AGENTS, LOCAL;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MEDICATION ADHERENCE;
PHOSPHONIC ACIDS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SOUTH AFRICA;
VAGINAL CREAMS, FOAMS, AND JELLIES;
YOUNG ADULT;
|
|
EID: 77954848121
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.329.5990.374 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
